Case | Subtype | WHO/ISUP grade | Age | Sex | Position | Size (cm) | Gene | Operation mode | Clinical symptoms | Clinical history | Follow-up |
---|---|---|---|---|---|---|---|---|---|---|---|
1 [1] | CCRCC | Grade 1 | 49 | Male | Right | 3.5 | NA | Partial nephrectomy | NA | None | 36 months |
2 [1] | CCRCC | Grade 1 | 32 | Female | Right | 3.2 | NA | Total nephrectomy | NA | None | 36 months |
3 [2] | CCRCC | NA | 69 | Male | Left | 4 | NA | Total nephrectomy | Haematuria and clots | Carcinoma of the bladder | NA |
4 [3] | CCPRCC | Grade 2 with focal 3 | 75 | Female | Left | 1.7 | NA | Partial nephrectomy | Routine physical examination | None | 6 months |
5 [4] | CCRCC | NA | 33 | Female | Right | 4 | No TFE3 or TFEB gene translocation | Total nephrectomy | Routine physical examination | None | 34 months |
6 [4] | CCRCC | NA | 66 | Female | Left | 8.5 | No TFE3 or TFEB gene translocation, no VHL gene isolation | Total nephrectomy | Routine physical examination | None | 40 months |
7present | CCRCC | Grades 1–2 | 38 | Female | Right | 2 | TSC2 and SETD2 variations | Partial nephrectomy | Discomfort in the right kidney | Lung cancer | 18 months |